IsomAb Ltd, a UK-based biotechnology company developing novel isoform-specific disease modifying antibody treatments, for peripheral arterial disease and other ischaemic conditions, has appointed Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback